Drug Database
Back to search

Switzerland· 66601001

VEYVONDI 650 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung

A von willebrand factor product containing vonicogum alfa, registered in Switzerland by Takeda Pharma AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC B02BD10

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVEYVONDI 650 IE, Pulver und Lösungsmi…ATCB02BD10REGISTER NO.66601001PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about vonicogum alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Von willebrand factor is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD10 (von willebrand factor), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search von willebrand factor products by name

Von willebrand factor · ATC B02BD10

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
vonicogum alfa
Manufacturer
Takeda Pharma AG
Country
Switzerland (CH)
ATC code
B02BD10
ATC class
Von Willebrand factor
Defined daily dose
1.5 TSD, E
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680666010013
    Set 1 Stk
    CHF 509.6

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for von willebrand factor.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check von willebrand factor against other medicinesHow interaction checks work

Von willebrand factor · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Von willebrand factor in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All von willebrand factor products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Veyvondi
  • Liechtenstein · Veyvondi
  • Norway · Veyvondi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dac47cb1-2b88-49d1-9c7e-fe0b7206fb4c
GET /v1/drugs/dac47cb1-2b88-49d1-9c7e-fe0b7206fb4c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "vonicogum alfa 650 UI",
  "valid_from": "2019-12-01",
  "limitations": "[{\"description\":\"Zur Prävention und Behandlung von Blutungen und operationsbedingten Blutungen bei der von-Willebrand-Krankheit für erwachsene Patienten, wenn eine alleinige Therapie mit Desmopressin (DDAVP) unwirksam oder kontraindiziert ist. VEYVONDI darf nicht zur Therapie von Hämophilie A eingesetzt werden.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-05-01\",\"validTo\":\"2027-04-30\"}]",
  "galenic_form": "Trockensub 650 IE c Solv",
  "therapeutic_area": null,
  "sl_inclusion_date": "2019-12-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about von willebrand factor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console